No benefit associated with moxifloxacin use for the treatment of recurrent drug-sensitive tuberculosis. ( Perumal R. et al. )
A Moxifloxacin-based Regimen for the Treatment of Recurrent, Drug-sensitive Pulmonary Tuberculosis: An Open-label, Randomized, Controlled Trial.
| Pr Pierre Tattevin Although moxifloxacin is one of the most in vitro and in vivo active anti-tuberculosis (TB) drug, large randomized trials showed … Suite